Introduction; Epidemiology of Hepatocellular Carcinoma: Sherman, M.; Impact of Peginterferon Maintenance Therapy on the Risk of Developing Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Virus: Shiffman, M.L.; Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis: Masuzaki, R.; Yoshida, H.; Omata, M.; Lipid Metabolism and Liver Disease in Hepatitis C Viral Infection: Koike, K.; Tsutsumi, T.; Yotsuyanagi, H.; Moriya, K.; Pathological Diagnosis at Early Stage: Reaching International Consensus: Kojiro, M.; Molecular Signature of Early Hepatocellular Carcinoma: Suriawinata, A.; Thung, S.N.; Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma: Kudo, M.; Hatanaka, K.; Maekawa, K.; Advances of Imaging for Hepatocellular Carcinoma: Choi, B.I.; Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma: Hatanaka, K.; Chung, H.; Kudo, M. et al.; Depiction of Portal Supply in Early Hepatocellular Carcinoma and Dysplastic Nodule: Value of Pure Arterial Ultrasound Imaging in Hepatocellular Carcinoma: Kudo, M.; Hatanaka, K. et al.; Contrast-Enhanced Ultrasound Techniques for Guiding and Assessing Response to Locoregional Treatments for Hepatocellular Carcinoma: Andreana, L.; Kudo, M.; Hatanaka, K.; Chung, H.; Minami, Y.; Maekawa, K.; Ruggiero, G.; Diagnostic and Treatment Algorithm of the Japanese Society of Hepatology: A Consensus-Based Practice Guideline: Izumi, N.; Will Gd-EOB-MRI Change the Diagnostic Algorithm in Hepatocellular Carcinoma?: Kudo, M.; Radiofrequency Ablation for Hepatocellular Carcinoma: Assistant Techniques for Difficult Cases: Inoue, T.; Minami, Y.; Chung, H. et al.; Local Ablation for Hepatocellular Carcinoma in Taiwan: Different Points between Japan, Asia and West: Lin, S.-M.; Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies: Lencioni, R.; Radiofrequency Ablation for Hepatocellular Carcinoma: Updated Review in 2010: Kudo, M.; Surgical Strategies for Hepatocellular Carcinoma with Special Reference to Anatomical Hepatic Resection and Intraoperative Contrast-Enhanced Ultrasonography: Arii, S.; Tanaka, S.; Mitsunori, Y. et al.; Liver Functional Reserve Estimation: State of the Art and Relevance to Local Treatments: Manizate, F.; Hiotis, S.P.; Labow, D. et al.; Chemoembolization for Unresectable Hepatocellular Carcinoma in Japan: Takayasu, K.; Treatment of Advanced Hepatocellular Carcinoma: Intraarterial Infusion Chemotherapy Combined with Interferon: Nagano, H.; Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma: Ueshima, K.; Kudo, M.; Takita, M. et al.; Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan: Kudo, M.; Ueshima, K.; Positioning and Indication of Sorafenib in the Treatment Algorithm and Real Practice Setting: Western and Eastern Approach - Asian Perspective: Lee, J.M.; Han, K.-H.; Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones: Yeh, S.-H.; Chen, P.-J.; Real Practice of Hepatocellular Carcinoma in Japan: Conclusions of the Japan Society of Hepatology 2009 Kobe Congress: Kudo, M.; Further Section; Author Index; Subject Index.
